MTNB
Matinas BioPharma Holdings Inc
NYSE MKT: MTNB · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.87% today
Updated 2026-04-29
Market cap
$3.91M
P/E ratio
—
P/S ratio
34.81x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Matinas BioPharma Holdings Inc (MTNB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-166.60%
ROA
-43.80%
Debt/equity
0.36x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-116075.00 | — | — | — |
| 2013 | — | $-3.71M | — | — | — |
| 2014 | $0.00 | $-10.22M | — | — | — |
| 2015 | $194494.00 | $-9.14M | -2,621.01% | -5,096.04% | -4,697.01% |
| 2016 | $0.00 | $-7.60M | — | — | — |
| 2017 | $149687.00 | $-15.49M | -5,919.56% | -11,024.61% | -10,345.91% |
| 2018 | $119750.00 | $-14.08M | -5,568.04% | -12,230.94% | -11,760.39% |
| 2019 | $89812.00 | $-17.37M | -12,408.96% | -21,067.38% | -19,343.35% |
| 2020 | $158333.00 | $-22.45M | -8,968.81% | -15,288.38% | -14,176.98% |
| 2021 | $33000.00 | $-23.28M | -44,090.91% | -74,954.55% | -70,554.55% |
| 2022 | $3.19M | $-21.00M | -423.15% | -771.33% | -658.63% |
| 2023 | $1.10M | $-22.94M | 100.00% | -2,168.43% | -2,093.25% |
| 2024 | $0.00 | $-24.25M | — | — | — |
| 2025 | $0.00 | $-10.35M | — | — | — |